Cover Image
Market Research Report
Product code 
721727

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Global Clinical Trials Review, H2, 2018

Published: | GlobalData | 74 Pages | Delivery time: 1-2 business days

Price

Back to Top
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Global Clinical Trials Review, H2, 2018
Published: August 31, 2018
GlobalData
Content info: 74 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

GlobalData's clinical trial report, "Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Global Clinical Trials Review, H2, 2018" provides an overview of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5226CTIDB

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Clinical Trials by G7 Countries: Proportion of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) to Hematological Disorders Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) to Hematological Disorders Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 22
  • Clinical Trials in E7 Countries by Trial Status 23
  • Clinical Trials by Phase 24
  • In Progress Trials by Phase 25
  • Clinical Trials by Trial Status 26
  • Clinical Trials by End Point Status 28
  • Subjects Recruited Over a Period of Time 29
  • Clinical Trials by Sponsor Type 30
  • Prominent Sponsors 31
  • Top Companies Participating in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials 33
  • Prominent Drugs 35
  • Clinical Trial Profile Snapshots 37

Appendix 72

  • Abbreviations 72
  • Definitions 72
  • Research Methodology 73
  • Secondary Research 73
  • About GlobalData 73
  • Contact Us 74
  • Disclaimer 74
  • Source 74

List of Tables

  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
  • Proportion of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 16
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
  • Proportion of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 21
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials by Phase, 2018* 24
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures

  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
  • Proportion of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 15
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 20
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
  • GlobalData Methodology 73